New Lung Cancer Screening Guidelines Will Save Lives Reaction was swift and positive last week to new draft guidelines from the U.S. Preventive Services Task Force lowering the requirements for low dose CT imaging as a screening tool for those at risk for lung cancer. Current recommendations call for low-dose CT scans for 55- to…

Nivolumab in the News The dosing schedule for nivolumab now includes a flat dose of 480 mg infused every 4 weeks (Q4W) for a majority of approved indications, including patients who received prior therapy for metastatic NSCLC. The U.S. Food and Drug Administration (FDA) approval provides an alternative to the previously available option of 240…